ClarioClario Precision Motion

Clario Precision Motion captures digital endpoints in clinical trials both in-clinic and at-home using the Opal V2C wearable sensor system. It quantifies gait, balance, and additional mobility across four core domains: walk tests including two-minute, six-minute, and open-ended walks; balance protocols across surfaces and stances; functional tests such as timed up and go, sit to stand, and 360-degree turns; and actigraphy for activity and sleep data.

The system delivers real-time performance-outcome data, ships with pre-configured standard assessments holding more than 140 validated outcome measures, and provides analytics through the Mobility Lab software platform with guided patient coaching. It is validated across indications including Parkinson's disease, multiple sclerosis, and spinocerebellar ataxia, and Clario reports that more than 1,000 researchers have used its Opal technology.